CRP and glioblastoma: In this specific context, both the elevated levels of CRP and reduced levels of Alb are commonly detected in any cancer type, including the GBM, and are principally prompted through hypoxia and necrotic tumor cell-induced mediators of systemic inflammation [40–42].